Celestia Diagnostics

About Celestia Diagnostics

Celestia Diagnostics is developing a blood test for the accurate diagnosis of Long COVID and other infection-associated chronic conditions, addressing the current lack of reliable testing methods. This diagnostic tool aims to enhance the treatment and management of these conditions by providing measurable insights into patient health.

```xml <problem> Millions of individuals suffer from Long COVID, a chronic condition triggered by COVID-19. The absence of reliable diagnostic tests for Long COVID hinders accurate diagnosis, effective treatment, and further research into the condition. </problem> <solution> Celestia Diagnostics is developing a blood test designed for the accurate diagnosis of Long COVID and other infection-associated chronic conditions. This diagnostic tool aims to bridge the gap between scientific research and clinical application, providing measurable insights into patient health. By offering a reliable diagnostic method, Celestia Diagnostics seeks to improve the treatment, management, and understanding of Long COVID. </solution> <features> - Blood test for the diagnosis of Long COVID - Diagnostic tool for other infection-associated chronic conditions </features> <target_audience> The primary audience includes medical professionals, researchers, and individuals seeking accurate diagnoses for Long COVID and related conditions. </target_audience> ```

What does Celestia Diagnostics do?

Celestia Diagnostics is developing a blood test for the accurate diagnosis of Long COVID and other infection-associated chronic conditions, addressing the current lack of reliable testing methods. This diagnostic tool aims to enhance the treatment and management of these conditions by providing measurable insights into patient health.

Where is Celestia Diagnostics located?

Celestia Diagnostics is based in Fort Worth, United States.

When was Celestia Diagnostics founded?

Celestia Diagnostics was founded in 2022.

Location
Fort Worth, United States
Founded
2022
Employees
3 employees
Major Investors
Southern Research

Find Investable Startups and Competitors

Search thousands of startups using natural language

Celestia Diagnostics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Celestia Diagnostics is developing a blood test for the accurate diagnosis of Long COVID and other infection-associated chronic conditions, addressing the current lack of reliable testing methods. This diagnostic tool aims to enhance the treatment and management of these conditions by providing measurable insights into patient health.

celestiadiagnostics.com50+
cb
Crunchbase
Founded 2022Fort Worth, United States

Funding

Major Investors

Southern Research

Team (<5)

No team information available.

Company Description

Problem

Millions of individuals suffer from Long COVID, a chronic condition triggered by COVID-19. The absence of reliable diagnostic tests for Long COVID hinders accurate diagnosis, effective treatment, and further research into the condition.

Solution

Celestia Diagnostics is developing a blood test designed for the accurate diagnosis of Long COVID and other infection-associated chronic conditions. This diagnostic tool aims to bridge the gap between scientific research and clinical application, providing measurable insights into patient health. By offering a reliable diagnostic method, Celestia Diagnostics seeks to improve the treatment, management, and understanding of Long COVID.

Features

Blood test for the diagnosis of Long COVID

Diagnostic tool for other infection-associated chronic conditions

Target Audience

The primary audience includes medical professionals, researchers, and individuals seeking accurate diagnoses for Long COVID and related conditions.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.